VSee Health Statistics
Total Valuation
VSee Health has a market cap or net worth of $4.67 million. The enterprise value is $5.55 million.
| Market Cap | 4.67M |
| Enterprise Value | 5.55M |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VSee Health has 48.60 million shares outstanding. The number of shares has increased by 113.54% in one year.
| Current Share Class | 48.60M |
| Shares Outstanding | 48.60M |
| Shares Change (YoY) | +113.54% |
| Shares Change (QoQ) | +53.12% |
| Owned by Insiders (%) | 11.34% |
| Owned by Institutions (%) | 4.51% |
| Float | 37.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | 0.28 |
| PB Ratio | 0.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41, with a Debt / Equity ratio of 0.34.
| Current Ratio | 0.41 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.89 |
Financial Efficiency
Return on equity (ROE) is -945.70% and return on invested capital (ROIC) is -203.23%.
| Return on Equity (ROE) | -945.70% |
| Return on Assets (ROA) | -34.90% |
| Return on Invested Capital (ROIC) | -203.23% |
| Return on Capital Employed (ROCE) | -148.52% |
| Weighted Average Cost of Capital (WACC) | 29.91% |
| Revenue Per Employee | $69,172 |
| Profits Per Employee | -$63,893 |
| Employee Count | 209 |
| Asset Turnover | 0.75 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VSee Health has paid $78,659 in taxes.
| Income Tax | 78,659 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.97% in the last 52 weeks. The beta is 0.49, so VSee Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -91.97% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 30.88 |
| Average Volume (20 Days) | 1,733,447 |
Short Selling Information
The latest short interest is 1.33 million, so 2.74% of the outstanding shares have been sold short.
| Short Interest | 1.33M |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 2.74% |
| Short % of Float | 3.54% |
| Short Ratio (days to cover) | 0.63 |
Income Statement
In the last 12 months, VSee Health had revenue of $14.46 million and -$13.35 million in losses. Loss per share was -$0.48.
| Revenue | 14.46M |
| Gross Profit | 6.69M |
| Operating Income | -10.73M |
| Pretax Income | -13.28M |
| Net Income | -13.35M |
| EBITDA | -8.14M |
| EBIT | -10.73M |
| Loss Per Share | -$0.48 |
Balance Sheet
The company has $1.35 million in cash and $2.14 million in debt, with a net cash position of -$789,017 or -$0.02 per share.
| Cash & Cash Equivalents | 1.35M |
| Total Debt | 2.14M |
| Net Cash | -789,017 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 6.32M |
| Book Value Per Share | 0.13 |
| Working Capital | -6.95M |
Cash Flow
In the last 12 months, operating cash flow was -$5.46 million and capital expenditures -$44,807, giving a free cash flow of -$5.50 million.
| Operating Cash Flow | -5.46M |
| Capital Expenditures | -44,807 |
| Depreciation & Amortization | 2.59M |
| Net Borrowing | -190,296 |
| Free Cash Flow | -5.50M |
| FCF Per Share | -$0.11 |
Margins
Gross margin is 46.30%, with operating and profit margins of -74.19% and -92.37%.
| Gross Margin | 46.30% |
| Operating Margin | -74.19% |
| Pretax Margin | -91.82% |
| Profit Margin | -92.37% |
| EBITDA Margin | -56.30% |
| EBIT Margin | -74.19% |
| FCF Margin | n/a |
Dividends & Yields
VSee Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -113.54% |
| Shareholder Yield | -113.54% |
| Earnings Yield | -280.38% |
| FCF Yield | -115.53% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 35.69% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VSee Health has an Altman Z-Score of -7.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.05 |
| Piotroski F-Score | 2 |